Correlation Between Magenta Therapeutics and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Magenta Therapeutics and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magenta Therapeutics and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magenta Therapeutics and C4 Therapeutics, you can compare the effects of market volatilities on Magenta Therapeutics and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magenta Therapeutics with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magenta Therapeutics and C4 Therapeutics.
Diversification Opportunities for Magenta Therapeutics and C4 Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Magenta and CCCC is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Magenta Therapeutics and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Magenta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magenta Therapeutics are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Magenta Therapeutics i.e., Magenta Therapeutics and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Magenta Therapeutics and C4 Therapeutics
Given the investment horizon of 90 days Magenta Therapeutics is expected to generate 0.26 times more return on investment than C4 Therapeutics. However, Magenta Therapeutics is 3.78 times less risky than C4 Therapeutics. It trades about 0.2 of its potential returns per unit of risk. C4 Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 70.00 in Magenta Therapeutics on September 1, 2024 and sell it today you would earn a total of 12.00 from holding Magenta Therapeutics or generate 17.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.33% |
| Values | Daily Returns |
Magenta Therapeutics vs. C4 Therapeutics
Performance |
| Timeline |
| Magenta Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| C4 Therapeutics |
Magenta Therapeutics and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Magenta Therapeutics and C4 Therapeutics
The main advantage of trading using opposite Magenta Therapeutics and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magenta Therapeutics position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Magenta Therapeutics vs. Assembly Biosciences | Magenta Therapeutics vs. Instil Bio | Magenta Therapeutics vs. Nuvation Bio | Magenta Therapeutics vs. Achilles Therapeutics PLC |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |